Busulfan, Fludarabine Phosphate, and Post-Transplant Cyclophosphamide in Treating Patients With Blood Cancer Undergoing Donor Stem Cell Transplant
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Tacrolimus
Related studies linked through entity extraction aliases.
Iguratimod in Kidney Transplant Recipients
- Status
- UNKNOWN
- Phase
- NA
The Efficacy and Safety of Tacrolimus in Refractory Rheumatoid Arthritis Patients for 6 Months and Long-term Treatment
- Status
- COMPLETED
- Phase
- PHASE4
NMA Haplo or MUD BMT for Newly Diagnosed Severe Aplastic Anemia
- Status
- COMPLETED
- Phase
- PHASE2
Omental Islet Transplant
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Therapeutic Drug Monitoring of Tacrolimus Biliary Concentrations for Liver-transplanted Patients (STABILE)
- Status
- COMPLETED
- Phase
- N/A
Validation of Population Pharmacokinetic Model Derived From Healthy Volunteer in Kidney Transplant Recipients
- Status
- UNKNOWN
- Phase
- N/A
Ocular Penetration of Topical Tacrolimus Eye Drops
- Status
- UNKNOWN
- Phase
- NA
Provision of TCRγδ T Cells and Memory T Cells Plus Selected Use of Blinatumomab in Naïve T-cell Depleted Haploidentical Donor Hematopoietic Cell Transplantation for Hematologic Malignancies Relapsed or Refractory Despite Prior Transplantation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Cytokine Induced Memory-like NK Cell Adoptive Therapy After Haploidentical Donor Hematopoietic Cell Transplantation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Bone Marrow Transplantation vs Standard of Care in Patients With Severe Sickle Cell Disease (BMT CTN 1503)
- Status
- COMPLETED
- Phase
- PHASE2
Identification of Drug-drug Interaction Between Tacrolimus and Mycophenolate Mofetil in Healthy Adults
- Status
- COMPLETED
- Phase
- PHASE1
To Compare the Effects of Immediate-release Tacrolimus and Astagraf XL on Donor-Specific Antibody (DSA) Formation and the Development of Immune Activation (IA) in de Novo Kidney Transplant Recipients
- Status
- COMPLETED
- Phase
- PHASE4
Treg Therapy in Subclinical Inflammation in Kidney Transplantation
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Sequential Targeting of Cluster of Differentiation 52 (CD52) and Tumor Necrosis Factor (TNF) Allows Early Minimization Therapy in Kidney Transplantation
- Status
- COMPLETED
- Phase
- NA
Sequential, Related Donor Partial Liver Transplantation Followed by Bone Marrow Transplantation for Hepatocellular Carcinoma (HCC)
- Status
- WITHDRAWN
- Phase
- PHASE2
Sirolimus Associated With Tacrolimus at Low Doses in Elderly Kidney Transplant Patients
- Status
- COMPLETED
- Phase
- PHASE4
Comparative Effectiveness Trial in the Treatment of Pediatric Plaque Morphea
- Status
- WITHDRAWN
- Phase
- PHASE1
Phase II Trial of Efprezimod Alfa (CD24Fc, MK-7110) for the Prevention of Acute Graft-Versus-Host Disease (GVHD) Following Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) (MK-7110-002)
- Status
- COMPLETED
- Phase
- PHASE2
Allo HSCT Using RIC for Hematological Diseases
- Status
- COMPLETED
- Phase
- PHASE2